Abstract
In 1971, the effects of the administration of normal human plasma to patients affected by mucopolysaccharidoses ( I and II) have been evaluated by Di Ferrante et al. In this report, the pattern of urinary acid mucopolysaccharide excretion after the administration of normal human plasma to various patients with mucopolysaccharidoses ( I and IV), new type of mucolipidosis, I -cell disease or GM1gangliosidosis (type I and type 2) has been studied using the cetylpyridinium chloride (CPC) precipitation method as described by Di Ferrante et al. Furthermore, the effects obtained with this treatment were also described.
